Validation of Radiomic Prognostic Vector in Ovarian Cancer (VROC)

• Research type

  Research Study

• Full title

  Validation and refinement of a Radiomic Prognostic Vector as a novel imaging biomarker to define tumour aggressiveness in multiple settings in ovarian cancer

• IRAS ID

  278423

• Contact name

  Andrea Rockall

• Contact email

  a.rockall@imperial.ac.uk

• Sponsor organisation

  Imperial College London

• Duration of Study in the UK

  1 years, 0 months, 0 days

• Research summary

  Ovarian cancer is the most lethal gynaecological disease, with a highly varying prognosis, depending on its type and extent. Computer tomography (CT) of the pelvis and the abdomen, with additional imaging of the thorax, is the currently used standard for the diagnosis and evaluation of disease spread.

  In this study, we plan to refine a previously discovered, imaging-based type of classification signature, called Radiomic Prognostic Vector (RPV), which could be used to help predict how tumour composition affect the outcome of the patient.

• REC name

  N/A

• REC reference

  N/A